These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36601480)

  • 1. Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker.
    Failmezger H; Hessel H; Kapil A; Schmidt G; Harder N
    Front Oncol; 2022; 12():964716. PubMed ID: 36601480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
    J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
    Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
    Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
    Laurinavicius A; Plancoulaine B; Rasmusson A; Besusparis J; Augulis R; Meskauskas R; Herlin P; Laurinaviciene A; Abdelhadi Muftah AA; Miligy I; Aleskandarany M; Rakha EA; Green AR; Ellis IO
    Virchows Arch; 2016 Apr; 468(4):493-502. PubMed ID: 26818835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.
    Valous NA; Lahrmann B; Halama N; Bergmann F; Jäger D; Grabe N
    Med Phys; 2016 Jun; 43(6):2936-2947. PubMed ID: 27277043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients.
    Radziuviene G; Rasmusson A; Augulis R; Grineviciute RB; Zilenaite D; Laurinaviciene A; Ostapenko V; Laurinavicius A
    Front Oncol; 2021; 11():774088. PubMed ID: 34858854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.
    Zilenaite D; Rasmusson A; Augulis R; Besusparis J; Laurinaviciene A; Plancoulaine B; Ostapenko V; Laurinavicius A
    Front Oncol; 2020; 10():950. PubMed ID: 32612954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescence.
    Faratian D; Christiansen J; Gustavson M; Jones C; Scott C; Um I; Harrison DJ
    J Vis Exp; 2011 Oct; (56):e3334. PubMed ID: 22064683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.
    Qaiser T; Mukherjee A; Reddy Pb C; Munugoti SD; Tallam V; Pitkäaho T; Lehtimäki T; Naughton T; Berseth M; Pedraza A; Mukundan R; Smith M; Bhalerao A; Rodner E; Simon M; Denzler J; Huang CH; Bueno G; Snead D; Ellis IO; Ilyas M; Rajpoot N
    Histopathology; 2018 Jan; 72(2):227-238. PubMed ID: 28771788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
    Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
    Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
    Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
    Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images.
    Ram S; Vizcarra P; Whalen P; Deng S; Painter CL; Jackson-Fisher A; Pirie-Shepherd S; Xia X; Powell EL
    PLoS One; 2021; 16(9):e0245638. PubMed ID: 34570796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples.
    Varghese F; Bukhari AB; Malhotra R; De A
    PLoS One; 2014; 9(5):e96801. PubMed ID: 24802416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of spatial tumor heterogeneity in immunohistochemistry staining images.
    Chervoneva I; Peck AR; Yi M; Freydin B; Rui H
    Bioinformatics; 2021 Jun; 37(10):1452-1460. PubMed ID: 33275142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkers.
    Spagnolo DM; Gyanchandani R; Al-Kofahi Y; Stern AM; Lezon TR; Gough A; Meyer DE; Ginty F; Sarachan B; Fine J; Lee AV; Taylor DL; Chennubhotla SC
    J Pathol Inform; 2016; 7():47. PubMed ID: 27994939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
    Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
    Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
    Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
    JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers.
    Rademakers SE; Rijken PF; Peeters WJ; Nijkamp MM; Barber PR; van der Laak J; van de Kogel AJ; Bussink J; Kaanders JH
    Cell Oncol (Dordr); 2011 Apr; 34(2):119-29. PubMed ID: 21302028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
    Xie Y; Olkhov-Mitsel E; Alminawi S; Slodkowska E; Downes MR
    Pathol Res Pract; 2021 Oct; 226():153607. PubMed ID: 34509050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.